Galderma Group (Switzerland) Market Outlook
| GALD Stock | 154.20 0.40 0.26% |
Slightly above 62% of Galderma Group's investor base is looking to short. The analysis of the overall prospects from investing in Galderma Group N suggests that many traders are, at the present time, alarmed. Galderma Group's investing sentiment can be driven by a variety of factors including economic data, Galderma Group's earnings reports, geopolitical events, and overall market trends.
Comfort Level 38
Alarmed
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Galderma Group's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Galderma Group N.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentWaiting |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Galderma Group N is 'Cautious Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Galderma Group N given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Galderma Group N, the advice is generated through an automated system that utilizes algorithms and statistical models.
Execute Galderma Group Advice
The Galderma recommendation should be used to complement the investment advice compiled from the current analysts' consensus on Galderma Group N. Macroaxis does not own or have any residual interests in Galderma Group N or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Galderma Group's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Soft | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Tiny | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
For the selected time horizon Galderma Group N has a Mean Deviation of 1.21, Semi Deviation of 1.39, Standard Deviation of 1.51, Variance of 2.29, Downside Variance of 2.19 and Semi Variance of 1.94Macroaxis provides investment recommendation on Galderma Group to complement and cross-verify current analyst consensus on Galderma Group N. Our trade recommendations engine determines the entity's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure Galderma Group N is not overpriced, please check out all Galderma Group fundamentals, including its shares owned by institutions, price to sales, and the relationship between the shares owned by insiders and price to book .
Galderma Group Trading Alerts and Improvement Suggestions
| About 36.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Galderma appoints Luigi La Corte as new CFO effective May 2026 - Investing.com India |
Galderma Group Returns Distribution Density
The distribution of Galderma Group's historical returns is an attempt to chart the uncertainty of Galderma Group's future price movements. The chart of the probability distribution of Galderma Group daily returns describes the distribution of returns around its average expected value. We use Galderma Group N price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Galderma Group returns is essential to provide solid investment analysis for Galderma Group.
| Mean Return | 0.05 | Value At Risk | -2.7 | Potential Upside | 2.15 | Standard Deviation | 1.51 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Galderma Group historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Galderma Group Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Galderma Group or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Galderma Group's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Galderma stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.02 | |
β | Beta against Dow Jones | 0.31 | |
σ | Overall volatility | 1.54 | |
Ir | Information ratio | -0.02 |
Galderma Group Volatility Alert
Galderma Group N has relatively low volatility with skewness of 0.13 and kurtosis of -0.12. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Galderma Group's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Galderma Group's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Galderma Group Fundamentals Vs Peers
Comparing Galderma Group's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Galderma Group's direct or indirect competition across all of the common fundamentals between Galderma Group and the related equities. This way, we can detect undervalued stocks with similar characteristics as Galderma Group or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Galderma Group's fundamental indicators could also be used in its relative valuation, which is a method of valuing Galderma Group by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Galderma Group to competition |
| Fundamentals | Galderma Group | Peer Average |
| Return On Equity | 0.0492 | -0.31 |
| Return On Asset | 0.0367 | -0.14 |
| Profit Margin | 0.08 % | (1.27) % |
| Operating Margin | 0.16 % | (5.51) % |
| Current Valuation | 37.25 B | 16.62 B |
| Shares Outstanding | 234.82 M | 571.82 M |
| Shares Owned By Insiders | 35.77 % | 10.09 % |
| Shares Owned By Institutions | 41.63 % | 39.21 % |
| Price To Book | 5.95 X | 9.51 X |
| Price To Sales | 7.81 X | 11.42 X |
| Revenue | 4.44 B | 9.43 B |
| Gross Profit | 3.25 B | 27.38 B |
| EBITDA | 959 M | 3.9 B |
| Net Income | 231 M | 570.98 M |
| Cash And Equivalents | 175 M | 2.7 B |
| Total Debt | 2.76 B | 5.32 B |
| Book Value Per Share | 25.31 X | 1.93 K |
| Cash Flow From Operations | 429.77 M | 971.22 M |
| Earnings Per Share | 1.22 X | 3.12 X |
| Price To Earnings To Growth | 0.91 X | 4.89 X |
| Target Price | 166.2 | |
| Market Capitalization | 36.61 B | 19.03 B |
| Total Asset | 12.62 B | 29.47 B |
| Retained Earnings | 5.68 B | 9.33 B |
| Annual Yield | 0 % | |
| Net Asset | 12.62 B | |
| Last Dividend Paid | 0.17 |
Galderma Group Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Galderma . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Galderma Group Buy or Sell Advice
When is the right time to buy or sell Galderma Group N? Buying financial instruments such as Galderma Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Galderma Group in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Small Cap ETFs Thematic Idea Now
Small Cap ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Small Cap ETFs theme has 187 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Cap ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Galderma Stock Analysis
When running Galderma Group's price analysis, check to measure Galderma Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galderma Group is operating at the current time. Most of Galderma Group's value examination focuses on studying past and present price action to predict the probability of Galderma Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galderma Group's price. Additionally, you may evaluate how the addition of Galderma Group to your portfolios can decrease your overall portfolio volatility.